Survivors | Nonsurvivors | P | |
---|---|---|---|
(n = 113) | (n = 86) | ||
Age (years) | 56 ± 17.4 | 61 ± 17 | 0.052 |
Males | 65 (57. 5) | 46 (53.5) | 0.570 |
Days in hospital before ICU admission | 2.5 (1–8) | 6 (1–16) | <0.001 |
APACHE II | 17.6 ± 7.9 | 24.8 ± 7.8 | <0.001 |
SOFA | 5 (2– 9) | 8 (6 –13) | <0.001 |
Comorbidities | |||
COPD | 20 (18) | 12 (14) | 0.443 |
CHF | 12 (10.8) | 9 (10.5) | 0.938 |
HIV | 6 (5.4) | 7 (8.1) | 0.443 |
Body mass index (kg/m2) | 27.2 ± 7.3 | 24.7 ± 5 | 0.031 |
History of DM | 26 (23) | 24 (27.9) | 0.430 |
Glucose tolerance | 0.359 | ||
Normal | 51 (45.1) | 41 (47.7) | |
Prediabetes | 40 (35.4) | 23 (26.7) | |
Diabetes | 22 (19.5) | 22 (25.6) | |
HbA1c (%) | 5.7 (5.3–6.3) | 5.8 (5.2–6.5) | 0.729 |
Serum glucose (mg/dL) | 122 (99–160) | 120 (95–167) | 0.909 |
Lactate (mg/dL) | 9.0 (6.3–15.3) | 18 (0–35) | <0.001 |
C-reactive protein (mg/dL) | 87 (27.5–150.4) | 102 (44 –234) | 0.067 |
Mechanical ventilation | 69 (61.1) | 68 (79.1) | 0.008 |
Hemodialysis | 15 (13.3) | 30 (34.9) | <0.001 |
Vasopressor support | 39 (34.5) | 64 (74.4%) | <0.001 |